Phase 3 Clinical Trial Observer
7 monthsInductive Quotient
- Observed qualification, initiation, and monitoring visits end to end — site visit structure, investigator qualification verification, and ISF/TMF filing requirements.
- Followed protocol deviation identification, communication to site staff, and CAPA documentation in real time across an active trial.
- Direct exposure to adverse event and SAE review, concomitant medication verification, and data integrity practices under ICH-GCP.



